Menu
Recruiting NCT06216717

Study of the Location of Motor Cortical Stimulation Electrodes in Chronic Neuropathic Refractory Patients

Observational Neuropathic Pain

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Neuropathic Pain. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Cortical stimulation has been used since 1991 to treat neuropathic pain. However, the underlying mechanisms are still incompletely understood and under-studied. In this protocol, the investigators aim to study the myeloarchitectonic and functional characteristics of areas activated by cortical epidural electrodes and to determine their relation to therapy response in chronic neuropathic refractory pain patients.

Primary outcome measures

  • Pourcentage of pain relief [Time frame: 1 year]
Secondary outcome measures (1)
  • location of leads on the postoperative imaging [Time frame: 1 month]

Eligibility criteria

Inclusion criteria

  • adults
  • patient implanted with a motor cortical stimulation system for chronic neuropathic refractory pain,
  • patient with available postoperative scanner

Exclusion Criteria: None

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Cohort

Study locations

France · 1 center
  • CHU NICE — Nice

Identifiers

NCT: NCT06216717 · 24Neurochir01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗